Insider Transactions in Q2 2021 at Day One Biopharmaceuticals, Inc. (DAWN)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jun 01 2021	Ai Day1 LLC	BUY Open market or private purchase	Direct	875,000 +8.53%	$14,000,000 $16.0 P/Share
Jun 01 2021	Ai Day1 LLC	BUY Conversion of derivative security	Direct	8,502,776 +50.0%	-
Jun 01 2021	Canaan Xi L.P. > 10% Shareholder	BUY Open market or private purchase	Direct	13,000 +0.12%	$208,000 $16.0 P/Share
Jun 01 2021	Canaan Xi L.P. > 10% Shareholder	BUY Conversion of derivative security	Direct	7,476,776 +21.15%	-
Jun 01 2021	Atlas Venture Fund Xi, L.P. > 10% Shareholder	BUY Open market or private purchase	Indirect	500,000 +50.0%	$8,000,000 $16.0 P/Share
Jun 01 2021	Atlas Venture Fund Xi, L.P. > 10% Shareholder	BUY Conversion of derivative security	Indirect	8,502,776 +50.0%	-
Jun 01 2021	Papanek Julie Grant Director	BUY Open market or private purchase	Indirect	13,000 +0.12%	$208,000 $16.0 P/Share
Jun 01 2021	Papanek Julie Grant Director	BUY Conversion of derivative security	Indirect	7,476,776 +21.15%	-
Jun 01 2021	Daniel J. Becker Director	BUY Open market or private purchase	Direct	5,000 +50.0%	$80,000 $16.0 P/Share
Jun 01 2021	John A. Josey	BUY Open market or private purchase	Direct	7,000 +8.83%	$112,000 $16.0 P/Share

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Value

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

Operation

Value

Type

Receive news related to Day One Biopharmaceuticals, Inc.